Project title
Open Access funding enabled and organized by Projekt DEAL. This study was funded by the ADDF (Alzheimer’s Drug Discovery Foundation: Grant 201810-2017419) to FL and IZ, the Instituto Carlos III (grants CP16/00041 and PI19/00144) to FL, the Robert Koch Institute through funds from the German Federal Ministry of Health (grant no. 1369–341) to IZ, and the Alzheimer Forschung Initiative (AFI, project no. 20026) to MS